NCT03530930View on ClinicalTrials.gov

Comarum Palustre in Knee Osteoarthritis and Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 29, 2018

Primary Completion Date

November 25, 2018

Study Completion Date

November 25, 2018

Conditions
OsteoarthritisDiabetes Mellitus
Interventions
DRUG

Comarum Palustre

Comarum Palustre tablets 500 mg BID, 1 month

Trial Locations (1)

630047

Laboratory of Clinical Immunopharmacology, Novosibirsk

All Listed Sponsors
lead

Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology

OTHER

NCT03530930 - Comarum Palustre in Knee Osteoarthritis and Diabetes | Biotech Hunter | Biotech Hunter